Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations

Podobne zapisy

• Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway
  od: Conti, Annalisa, i wsp.
  Wydane: (2015)
• Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines
  od: Weißbach, Susann, i wsp.
  Wydane: (2020)
• Oncogenic Kras Requires Simultaneous PI3K Signaling to Induce ERK Activation and Transform Thyroid Epithelial Cells in Vivo
  od: Miller, Kelly A., i wsp.
  Wydane: (2009)
• Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
  od: Catalano, Antonella, i wsp.
  Wydane: (2021)
• EZH2 Protein Expression Associates With the Early Pathogenesis, Tumor Progression and Prognosis of Non-small Cell Lung Carcinoma
  od: Behrens, Carmen, i wsp.
  Wydane: (2013)